Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 337-345

  Liu, Yang ^a   Wang, Huanhuan ^b   Lin, Tianxin ^c   Wei, Quanfang ^b   Zhi, Yi ^a   Yuan, Fang ^a   Song, Bo ^a   Yang, Jin ^b   Chen, Zhiwen ^a  

^a SOUTHWEST HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bladder cancer; Chinese population; Polymorphism; Smoking; Xeroderma pigmentosum complementary group C

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; XPC GENE;

AGED; AMINO ACID SUBSTITUTION; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, GENETIC; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84861533093     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1759     Document Type: Article

References (36)

1. Baris D, Karagas MR, Verrill C, et al: A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 101: 1553-1561, 2009.
2. Hirao Y, Kim WJ and Fujimoto K: Environmental factors promoting bladder cancer. Curr Opin Urol 19: 494-499, 2009.
3. IARC Working Group on the Evaluations of Carcinogenic Risks to Humans: Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83: 1-1438, 2004.
4. Smith LE, Denissenko MF, Bennett WP, et al: Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst 92: 803-811, 2000. (Pubitemid 30368036)
5. Yue W, Santen RJ, Wang JP, et al: Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 86: 477-486, 2003. (Pubitemid 37412587)
6. Hussain SP, Schwank J, Staib F, Wang XW and Harris CC: TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26: 2166-2176, 2007. (Pubitemid 46536641)
7. Upadhyay D and Kamp DW: Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med (Maywood) 228: 650-659, 2003. (Pubitemid 37163254)
8. Foster F: New Zealand Cancer Registry report. Natl Cancer Inst Monogr 53: 77-80, 1979.
9. Wood RD, Mitchell M, Sgouros J and Lindahl T: Human DNA repair genes. Science 291: 1284-1289, 2001. (Pubitemid 32173086)
10. Packer BR, Yeager M, Burdett L, et al: SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-D621, 2006.
11. Sugasawa K, Ng JM, Masutani C, et al: Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 2: 223-232, 1998. (Pubitemid 128373647)
12. Min JH and Pavletich NP: Recognition of DNA damage by the Rad4 nucleotide excision repair protein. Nature 449: 570-575, 2007.
13. Thoma BS and Vasquez KM: Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog 38: 1-13, 2003. (Pubitemid 37122315)
14. Tapias A, Auriol J, Forget D, et al: Ordered conformational changes in damaged DNA induced by nucleotide excision repair factors. J Biol Chem 279: 19074-19083, 2004. (Pubitemid 38623338)
15. Brown KL, Roginskaya M, Zou Y, Altamirano A, Basu AK and Stone M: Binding of the human nucleotide excision repair proteins XPA and XPC/HR23B to the 5R-thymine glycol lesion and structure of the cis-(5R,6S) thymine glycol epimer in the 5'-GTgG-3' sequence: destabilization of two base pairs at the lesion site. Nucleic Acids Res 38: 428-440, 2010.
16. Chen Z, Yang J, Wang G, Song B, Li J and Xu Z: Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res 67: 4578-4585, 2007. (Pubitemid 46910162)
17. Kraemer KH, Lee MM, Andrews AD and Lambert WC: The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130: 1018-1021, 1994. (Pubitemid 24255035)
18. Sands AT, Abuin A, Sanchez A, Conti CJ and Bradley A: High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 377: 162-165, 1995.
19. Francisco G, Menezes PR, Eluf-Neto J and Chammas R: XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet 16: 724-734, 2008. (Pubitemid 351753369)
20. Qiu L, Wang Z and Shi X: Associations between XPC polymorphisms and risk of cancers: A meta-analysis. Eur J Cancer 44: 2241-2253, 2008.
21. Zhu Y, Lai M, Yang H, et al: Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis 28: 698-703, 2007. (Pubitemid 46523367)
22. de Verdier PJ, Sanyal S, Bermejo JL, Steineck G, Hemminki K and Kumar R: Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat Res 694: 39-44, 2010.
23. Hu Z, Wang Y, Wang X, et al: DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer 115: 478-483, 2005. (Pubitemid 40663754)
24. Ribas G, Gonzalez-Neira A, Salas A, et al: Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes. Hum Genet 118: 669-679, 2006. (Pubitemid 43225012)
25. Marin MS, Lopez-Cima MF, Garcia-Castro L, Pascual T, Marron MG and Tardon A: Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 13: 1788-1793, 2004. (Pubitemid 39482957)
26. Zhang L, Zhang Z and Yan W: Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 359: 150-155, 2005. (Pubitemid 41116307)
27. Garcia-Closas M, Malats N, Real FX, et al: Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15: 536-542, 2006.
28. Chen M, Kamat AM, Huang M, et al: High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 28: 2160-2165, 2007. (Pubitemid 47543377)
29. Gangwar R, Mandhani A and Mittal RD: XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. J Cancer Res Clin Oncol 136: 779-786, 2010.
30. Khan SG, Muniz-Medina V, Shahlavi T, et al: The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res 30: 3624-3631, 2002. (Pubitemid 34919219)
31. Pashos CL, Botteman MF, Laskin BL and Redaelli A: Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract 10: 311-322, 2002. (Pubitemid 35231626)
32. Ross RK, Jones PA and Yu MC: Bladder cancer epidemiology and pathogenesis. Semin Oncol 23: 536-545, 1996. (Pubitemid 26362215)
33. Marcus PM, Hayes RB, Vineis P, et al: Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 9: 461-467, 2000. (Pubitemid 30313888)
34. Castelli EC, Mendes-Junior CT, Viana de Camargo JL and Donadi EA: HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population. Tissue Antigens 72: 149-157, 2008. (Pubitemid 352009823)
35. Wu XR: Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5: 713-725, 2005.
36. Yang J, Xu Z, Li J, et al: XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome. J Urol 184: 336-343, 2010.